Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Analysis of Antitumor Effects of CAR-T Cells in Mice with Solid Tumors.

Rodriguez-Garcia A, Watanabe K, Guedan S.

Methods Mol Biol. 2020;2086:251-271. doi: 10.1007/978-1-0716-0146-4_19.


Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy.

Rodríguez-García A, Morales ML, Garrido-García V, García-Baquero I, Leivas A, Carreño-Tarragona G, Sánchez R, Arenas A, Cedena T, Ayala RM, Bautista JM, Martínez-López J, Linares M.

Antioxidants (Basel). 2019 Oct 24;8(11). pii: E508. doi: 10.3390/antiox8110508.


T-cell target antigens across major gynecologic cancers.

Rodriguez-Garcia A, Minutolo NG, Robinson JM, Powell DJ.

Gynecol Oncol. 2017 Jun;145(3):426-435. doi: 10.1016/j.ygyno.2017.03.510. Epub 2017 Apr 2. Review.


Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo.

Xu XJ, Song DG, Poussin M, Ye Q, Sharma P, Rodríguez-García A, Tang YM, Powell DJ.

Oncotarget. 2016 Dec 13;7(50):82354-82368. doi: 10.18632/oncotarget.10510.


Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression.

Rodríguez-García A, Giménez-Alejandre M, Rojas JJ, Moreno R, Bazan-Peregrino M, Cascalló M, Alemany R.

Clin Cancer Res. 2015 Mar 15;21(6):1406-18. doi: 10.1158/1078-0432.CCR-14-2213. Epub 2014 Nov 12.


A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology.

Laborda E, Puig-Saus C, Rodriguez-García A, Moreno R, Cascalló M, Pastor J, Alemany R.

Mol Ther. 2014 May;22(5):986-98. doi: 10.1038/mt.2014.7. Epub 2014 Jan 22.

Supplemental Content

Loading ...
Support Center